Previous studies have demonstrated that a psychostimulant drug used to treat ADHD, methylphenidate, normalized the effects of DRD4 in PFC pyramidal neurons during the performance of cognitive tasks (Volkow et al., 2008; Peterson et al., 2009; Tomasi et al., 2011). The gene discussed is DRD4; the disease is attention deficit-hyperactivity disorder.